ALTA LIFE SCIENCES retweeted
DeepUll seeks to replace 40-year-old sepsis Dx approach firstwordhealthtech.com/stor… #sepsis #DeepUll #moleculardiagnostics #healthtech #advancedIVD #AI #innovation
ALTA LIFE SCIENCES retweeted
Los fondos obtenidos por la 'start up' fundada en 2020 por Jordi Carrera y Rafel Bru se utilizarán para avanzar en el desarrollo de su plataforma de reconocimiento de la sepsis. @tinofernandez @exp_startup expansion.com/expansion-empl…
ALTA LIFE SCIENCES retweeted
DeepUll consigue 13 millones para avanzar en el diagnóstico de la sepsis dozz.es/mah0q2
ALTA LIFE SCIENCES retweeted
#PCBCommunity | #DeepUll, based in #PCB_UB, raises €13M Series B financing to progress its first-in-class early #sepsis recognition platform towards the market
@CDTI_innovacion @CienciaGob @ICOgob @_AltaLS @KurmaPartners @ui_invest #MedicalDiagnostics
pcb.ub.edu/en/deepull-raises…
ALTA LIFE SCIENCES retweeted
binx health announced today the appointment of Todd Bennett as CCO. Todd is an accomplished industry veteran, having held multiple executive leadership roles at several high-growth diagnostic and healthcare technology companies. Read more here: bwnews.pr/3COHouI
ALTA LIFE SCIENCES retweeted
binx health brings convenient access to high-quality reference laboratory-based testing with the potential to drive better outcomes. Learn more about how we can service your organization or community: mybinxhealth.com/about-us#co… #COVID19 #STItesting
ALTA LIFE SCIENCES retweeted
We are pleased to announce that we have signed an exclusive worldwide licensing agreement with Oculis to develop and commercialize a potentially disease modifying therapy to protect and prevent damage to the optic nerve and retina. #glaucoma #opticneuritis
accure.health/oculis-strengt…
Happy to announce that Oculis Strengthens Leading Ophthalmology Pipeline by InLicensing Neuroprotective Drug Candidate for Glaucoma from @AccureTherapeut
altals.com/blog/2022/03/02/o…
ALTA LIFE SCIENCES retweeted
MYC inhibition halts metastatic breast cancer progression by blocking tumor growth, invasion & seeding. Congratulations @peptomyc Team and @VHIO! @LauraSoucek & Daniel Massó-Vallés!
🗞 Published in @CRC_AACR, a study led by VHIO’s @LauraSoucek, first-authored by Daniel Massó-Vallés at VHIO spin-off @peptomyc, shows that MYC inhibition by Omomyc halts disease progression in metastatic breast cancer.
➕ bit.ly/VHIO-OmomycBreast
ALTA LIFE SCIENCES retweeted
#JustPublished! MYC inhibition is anti-metastatic in #BreastCancer by Massó-Vallés, @LauraSoucek et al.
bit.ly/3tfYP3l
@peptomyc @VHIO #openaccess
ALTA LIFE SCIENCES retweeted
"Parar la proteína 'myc' significa parar el crecimiento de tumores humanos"
En el #Canal24Horas han hablado con Laura Soucek, jefa del grupo del Instituto de Oncología Vall d'Hebron (@VHIO)
rtve.es/play/videos/la-tarde…
ALTA LIFE SCIENCES retweeted
"𝑈𝑛 𝑓𝑎̀𝑟𝑚𝑎𝑐 𝑟𝑒𝑣𝑜𝑙𝑢𝑐𝑖𝑜𝑛𝑎𝑟𝑖 𝑞𝑢𝑒 𝑒𝑙𝑖𝑚𝑖𝑛𝑎 𝑐𝑒̀𝑙·𝑙𝑢𝑙𝑒𝑠 𝑐𝑎𝑛𝑐𝑒𝑟𝑜𝑠𝑒𝑠"
@LauraSoucek, CEO de @peptomyc, fue entrevistada ayer en el programa REVOLUCIÓ 4.0 de @CatalunyaRadio
cutt.ly/cOKeyA2
ALTA LIFE SCIENCES retweeted
Peptomyc is hiring! We are looking for a Clinical distribution and Logistics manager.
More info here: bit.ly/3onOh06
If you are interested in this offer please send your CV to [email protected]
ALTA LIFE SCIENCES retweeted
Con motivo del día ᴅɪ́ᴀ Iɴᴛᴇʀɴᴀᴄɪᴏ́ɴᴀʟ ᴅᴇ ʟᴀ Eᴅᴜᴄᴀᴄɪᴏ́ɴ, @BusinessInsider entrevista a 61 empresarios, inversores, directivos e investigadores; comentan qué echaron en falta y qué cambiarían de su época en las aulas.
bit.ly/3ICgJTX @LauraSoucek
🎓 @LauraSoucek, profesora de investigación en ICREA y fundadora de @Peptomyc: "En mi caso, me hubiera gustado tener más información sobre las posibilidades de intercambio entre la carrera académica y el sector privado en el que iba a trabajar después de graduarme".
ALTA LIFE SCIENCES retweeted
#VentureCapital: @peptomyc logra 8,6 millones de sus socios y busca más inversores expansion.com/catalunya/2022… a través de @expansioncom
ALTA LIFE SCIENCES retweeted
Very happy to welcome Dr Michel Detheux as Independent Chair to ONA’s board of directors. linkedin.com/posts/ona-thera…
ALTA LIFE SCIENCES retweeted
I am thrilled to welcome Dr Michel Detheux as Independent Chair of ONA’s board of directors.
Very happy to welcome Dr Michel Detheux as Independent Chair to ONA’s board of directors. linkedin.com/posts/ona-thera…
ALTA LIFE SCIENCES retweeted
Enhorabuena a @SanifitLabs por este broche de oro a estos 17 años de compromiso y esfuerzo. Mérito de @perellojoan y todo el equipo, gracias a la apuesta de @CaixaCR @YsiosCapital @_AltaLS @InvivoCapital e #innvierte de @CDTIoficial
sanifit.com/vifor-pharma-to-…
ALTA LIFE SCIENCES retweeted
#VentureCapital: @ViforPharmaES adquirirá @SanifitLabs, participada por @YsiosCapital, @CaixaCR, @_AltaLS, ColumbusVP, Healthequity y el @CDTIoficial bit.ly/3cz4RnF